Within this landscape, tirzepatide stands out because of its dual GIP/GLP-1 mechanism, which produces superior weight loss compared to GLP-1-only medications
In a 2010 clinical trial, for example, subjects who received tesamorelin ended with an average 18% decrease in visceral fat compared to placebo.27 This fat-reducing quality is what makes tesamorelin an attractive non-GLP-1 peptide option
BDNF, brain-derived neurotrophic factor, acts as fertilizer for the brain
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
In rat studies, administration of 10 mcg per kg per day for seven days produced region-specific increases in serotonin synthesis
Their effects are not isolated